Tags - Opinion

Invest and innovate to keep UK life sciences globally competitive

Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.

A new strategy for cancer in Northern Ireland

The Department of Health Northern Ireland has launched a consultation for a 10-year strategy to tackle cancer. 

Our view of the latest NICE consultation

NICE is launching its final consultation on proposed changes to the way it develops recommendations across its health technology evaluation programmes.

Let’s put research at the heart of the NHS

On International Clinical Trials Day, Colette Goldrick explains our call for the new Health and Care Bill to ensure NHS organisations conduct and resource clinical research.

A vision for the future of UK clinical research

The government has published its vision for the future of clinical research, setting out how it intends to capitalise on the successes of the past year.

Let's make rare disease treatments less rare

ABPI President Haseeb Ahmad says that genome sequencing and advanced therapies give hope to people with rare diseases and their families – we have to get them into the hands of patients.

Evolving the UK health system to support innovation for the rare disease community

Nicola Redfern, General Manager of bluebird bio in the UK, describes the commercial challenges for rare disease medicines in the UK and reflects on the opportunities of gene therapies. 

Rare Disease 101 - the first cross-rare disease course for healthcare professionals

Dr Lucy McKay, CEO of the charity Medics4Rare Diseases tells us why their new educational module – Rare Disease 101 - should be essential for all healthcare professionals.

There’s nothing we can’t do or achieve, but people with thalassaemia need understanding and support

Thalassaemia major is a serious, genetic blood disorder. Roanna Maharaj was diagnosed with a severe form of the disease as a baby in the Caribbean. This is her story.

Research must be for everyone, says ABPI President

In its second annual clinical trials report launched this week, the ABPI is calling for the research community to work with Government, funders, and the public to tackle issues around diversity and inclusion in research. 

A Global Science Superpower: The Future of Medicines Valuation

The ABPI partnered with Reform on an event on the NICE Methods Review, titled 'A Global Science Superpower: The Future of Medicines Valuation.
;